Correction: The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a
Robert Hoffrogge1, Anna Karachunskaya1, Neele Heitmann1
1Department of Neurology, St. Josef-Hospital, Bochum, Germany.
Frontiers in Immunology
|August 8, 2025
Abstract:
[This corrects the article DOI: 10.3389/fimmu.2025.1554999.].
Insights
This study corrects a previously published article DOI. The correction ensures accurate citation and retrieval of scientific information for researchers.
Area of Science:
- Immunology
- Biomedical Research
Context:
- Correction of a previously published article DOI.
- Ensuring accurate scientific record-keeping.
Purpose:
- To rectify an error in the article's Digital Object Identifier (DOI).
- To facilitate correct citation and access to the research.
Summary:
- The article DOI: 10.3389/fimmu.2025.1554999 has been corrected.
- This ensures the integrity of the scientific literature.
Impact:
- Improved discoverability of the research article.
- Enhanced reliability of scientific databases and citation indexes.
More Related Videos
10:50Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
7.8K
06:19Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
3.8K